Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice
Tepotinib治疗MET 14号外显子跳跃型非小细胞肺癌患者的疗效和安全性:VISION研究中患者亚组的结局及其临床意义
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-21-2733
Le, Xiuning; Sakai, Hiroshi; Felip, Enriqueta; Veillon, Remi; Garassino, Marina Chiara; Raskin, Jo; Cortot, Alexis B; Viteri, Santiago; Mazieres, Julien; Smit, Egbert F; Thomas, Michael; Iams, Wade T; Cho, Byoung Chul; Kim, Hye Ryun; Yang, James Chih-Hsin; Chen, Yuh-Min; Patel, Jyoti D; Bestvina, Christine M; Park, Keunchil; Griesinger, Frank; Johnson, Melissa; Gottfried, Maya; Britschgi, Christian; Heymach, John; Sikoglu, Elif; Berghoff, Karin; Schumacher, Karl-Maria; Bruns, Rolf; Otto, Gordon; Paik, Paul K